Search Partner Service

In this section, you can add new consortium or search for partners or R&D&i project proposals in Animal Health that are already defined or in their initial stage. The scope of the projects can be national, European or international calls, or private projects.

Biogelator

Material based on short, tunable amphipathic hexapeptide sequences that form hydrogels upon addition of aqueous media The technology can be used as a generic controlled drug delivery formulation for the treatment of various chronic diseases, suited for the extended release of small molecule drugs and biologicals of medium- to high molecular weight drugs. Additionally, it can be used in other areas like tissue engineering, where soft matters are highly valuable. Proof of concept The BioGelator technology was first developed for pain therapy, and other biomedical and therapeutic applications are currently under investigation. The in vivo efficacy of BioGelator formulations was demonstrated via monitoring of opioid-induced antinociceptive effects in mice using the tail-flick test.

volver

Imprimir

Una iniciativa de

Ayuda PTR2022-001249 financiada por:

UNION EUROPEA - FONDO EUROPEO DE DESARROLLO REGIONAL

Área Personal

Biogelator